Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award
Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland š§ šµš±. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases š§¬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimerās and Parkinsonās disease š§Ŗ. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters š. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies š.
Profile
Education š
Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 š . She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 š§Ŗ. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 š. Her academic growth includes training in medical genetics from 2012 to 2020 š§¬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence š”.
Experience šØāš«
Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS š©āš¬. She was a Research Scientist in New York (1999ā2000) š½ and has led the Laboratory of Neurobiology since 2004 š§ . She became Full Professor in 2022 šļø. She also lectured at the National High Medical School in Pila (2012ā2018) š. Her career blends hands-on research, global collaboration, and dedicated academic leadership š. She continues to mentor, publish, and drive innovations in neurology and neurochemistry š
Awards & Recognitions š
Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) š. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research š. A section and associate editor for journals across the USA, UK, and Poland š, sheās a key figure in scientific publishing šļø. Sheās affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books š.
Research Interests š¬
Research Focus:
Her research spans lipid metabolism in hypoxia š§«, cerebral sterols š§ , neurotransmitters (serotonin, dopamine) š§Ŗ, apoptosis in aging and disease (Alzheimerās, Parkinsonās) š, and gene polymorphisms (MTHFR, MAO-B, PARK) š§¬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration š§ . Since 2009, sheās focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics āļø. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry š. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases š.